학술논문

Stromal Vascular Fraction Reverses the Age-Related Impairment in Revascularization following Injury
Document Type
Report
Source
Journal of Vascular Research. December 1, 2022, Vol. 59 Issue 6, p343, 15 p.
Subject
United States
Language
English
ISSN
1018-1172
Abstract
Adipose-derived stromal vascular fraction (SVF) has emerged as a potential regenerative therapy, but few studies utilize SVF in a setting of advanced age. Additionally, the specific cell population in SVF providing therapeutic benefit is unknown. We hypothesized that aging would alter the composition of cell populations present in SVF and its ability to promote angiogenesis following injury, a mechanism that is T cell-mediated. SVF isolated from young and old Fischer 344 rats was examined with flow cytometry for cell composition. Mesenteric windows from old rats were isolated following exteriorization-induced (EI) hypoxic injury and intravenous injection of one of four cell therapies: (1) SVF from young or (2) old donors, (3) SVF from old donors depleted of or (4) enriched for T cells. Advancing age increased the SVF T-cell population but reduced revascularization following injury. Both young and aged SVF incorporated throughout the host mesenteric microvessels, but only young SVF significantly increased vascular area following EI. This study highlights the effect of donor age on SVF angiogenic efficacy and demonstrates how the ex vivo mesenteric-window model can be used in conjunction with SVF therapy to investigate its contribution to angiogenesis. Keywords: Aging, Cell therapy, Angiogenesis, Revascularization, Injury, T cells
Author(s): Gabrielle Rowe (corresponding author) [a,b]; David S. Heng [a]; Jason E. Beare [a,c]; Nicholas A. Hodges [d]; Evan P. Tracy [a,b]; Walter L. Murfee [d]; Amanda J. LeBlanc [a,e] [...]